pharmaphorum
APRIL 6, 2021
From #MeToo to Black Lives Matter, as a society we have been discussing the relationship between representation and equality more than ever over the last few years. . But while progress is being made in so many areas, people with disabilities are still struggling to find a voice above the accepted narrative, says Ross Lannon, the 27-year-old blogger and multi-media content creator behind A Life on Wheels.
Pharma Times
APRIL 7, 2021
The NIHR-funded trial will assess whether removing small fibroids and endometrial polyps improves fertility and live births
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NY Times
APRIL 5, 2021
A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.
Outsourcing Pharma
APRIL 8, 2021
The collaboration will enable Charles River clients to access Valenceâs artificial intelligence platform in their pharmaceutical development projects.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
APRIL 8, 2021
A digital tool used to treat attention-deficit hyperactivity disorder (ADHD) is being tested to see if it can help counter lingering, fuzzy thinking in COVID-19 survivors, a condition sometimes known as ‘brain fog’ An app called EndeavorRx – developed by PureTech Health-backed Akili Interactive – will be tested in two clinical trials to see if it can improve cognitive function in people who have recovered from COVID-19 but still show cognitive problems weeks or months later.
Pharma Times
APRIL 6, 2021
NHS England is rolling out Roche's new combined treatment Phesgo, which drastically cuts administration time
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Drug Patent Watch
APRIL 7, 2021
How Much Time Are You Wasting on Manual, Repetitive Tasks? Stop wasting time on repetitive reports: Contact us Are your staff burdened with manual, repetitive tasks, like data collection, and…. The post Stop paying your staff to make repetitive reports appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
APRIL 9, 2021
The FDA says it has uncovered “deficiencies” in the marketing application for Provention Bio’s much-anticipated drug teplizumab for the prevention of type 1 diabetes (T1D) that could delay its review. The issues are holding up discussions between the agency and company about labeling and post-marketing requirements for teplizumab, and are concentrated around the pharmacokinetics data for the antibody, and whether it is comparable to the drug that its original developer Eli Lill
Pharma Times
APRIL 9, 2021
The drug was discovered through an AI-design platform within just eight months of project initiation
NY Times
APRIL 9, 2021
With supplies from Johnson & Johnson set to fall 86 percent, a White House official warned that the vaccine would be scarce until a troubled Baltimore plant gains regulatory approval.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Outsourcing Pharma
APRIL 5, 2021
The April 6 webinar, Clinical Development Innovations, will touch upon artificial intelligence, machine learning, ethics and other impactful issues.
pharmaphorum
APRIL 8, 2021
COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . The 2021 WIRED Health conference took a broad view of the current pandemic situation, with speakers ranging from geneticists to intensive care doctors.
Pharma Times
APRIL 8, 2021
Kesimpta is the first self-administered B-cell therapy for patients with relapsing forms of multiple sclerosis
NY Times
APRIL 8, 2021
Slovakia says that Sputnik V doses it received did “not have the same characteristics and properties” as a version endorsed by a respected British medical journal.
Outsourcing Pharma
APRIL 7, 2021
Especially with the COVID-19 pandemic impacting studies, the company says, putting patients at the center of studies and trial tech must be top priority.
pharmaphorum
APRIL 6, 2021
People in the UK will start receiving doses of Moderna’s COVID-19 vaccine in around two weeks’ time, according to vaccines minister Nadhim Zahawi. The roll-out of the third coronavirus shot will come as the UK exits its second lockdown round, and in time to offset an anticipated dip in supply of the Oxford University/AstraZeneca AZD1222 vaccine in the coming weeks.
Pharma Times
APRIL 9, 2021
The combination is not considered to be a cost-effective use of NHS resources in this setting
Drug Patent Watch
APRIL 5, 2021
Annual Drug Patent Expirations for XEPI Xepi is a drug marketed by Ferrer Internacional and is included in one NDA. It is available from two suppliers. There are three patents…. The post New patent expiration for Ferrer Internacional drug XEPI appeared first on DrugPatentWatch - Make Better Decisions.
Outsourcing Pharma
APRIL 8, 2021
The AWARE for All virtual event series aims to educate and engage the public as important partners in clinical trials and development of new treatments.
pharmaphorum
APRIL 8, 2021
Gilead’s $21 billion purchase of Immunomedics and its potential blockbuster Trodelvy continues to pay off, as the drug has now been approved by the FDA for triple-negative breast cancer. . Trodelvy (sacituzumab govitecan) was granted accelerated approval by the FDA in April last year, and is now indicated for adults with triple-negative breast cancer who have received at least two previous therapies for metastatic disease.
Pharma Times
APRIL 9, 2021
A subcutaneous formulation will now be available to treat relapsing-remitting multiple sclerosis
NY Times
APRIL 7, 2021
Una nueva formulación que está entrando en ensayos clínicos en Brasil, México, Tailandia y Vietnam podría cambiar la forma en que el mundo combate la pandemia.
Outsourcing Pharma
APRIL 7, 2021
A leader from the global CRO discusses how putting the patient first in clinical research is essential to discovering new therapies for orphan diseases.
pharmaphorum
APRIL 7, 2021
Jan van de Winkel has overseen one of biotech’s big success stories since he took over Genmab’s CEO in 2010. He spoke to pharmaphorum’s news editor Richard Staines to outline his plans to create a European biotech powerhouse. . The last ten years has seen Denmark’s Genmab become one of biotech’s big success stories. Under the leadership of CEO Jan van de Winkel it has gone from financially precarious position following the stock market crash in the late noughties, to the darling of the Nasdaq wi
Pharma Times
APRIL 7, 2021
The £20 million fund will boost the UK's life sciences manufacturing capabilities, creating new economic opportunities and highly skilled jobs
Drug Patent Watch
APRIL 9, 2021
Annual Drug Patent Expirations for ABRAXANE Abraxane is a drug marketed by Abraxis Bioscience and is included in one NDA. It is available from one supplier. There are twelve patents…. The post New patent expiration for Abraxis Bioscience drug ABRAXANE appeared first on DrugPatentWatch - Make Better Decisions.
Outsourcing Pharma
APRIL 7, 2021
A father of two boys with Duchenne muscular dystrophy is running the Austin Marathon to raise funds toward pursuit of a cure for the rare, fatal disease.
pharmaphorum
APRIL 7, 2021
Genmab’s CEO Jan van de Winkel has said he would consider spinning out a smaller autoimmune diseases biotech, while ruling out any interest in a merger with big pharma. . In an interview with pharmaphorum, van de Winkel noted that the company’s drugs could be used for diseases outside of cancer, where Copenhagen-based Genmab first made its mark. A drug it originally developed to treat leukaemia has been repurposed by Novartis as a treatment for multiple sclerosis.
Pharma Times
APRIL 6, 2021
The 2021 Communications Awards have opened their doors for entry, inviting the very best in pharma communications to come forward and claim first prize.
Drug Patent Watch
APRIL 9, 2021
Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. There are sixteen patents protecting this drug. XHANCE drug…. The post New patent expiration for Optinose Us drug XHANCE appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Marketing Network
APRIL 9, 2021
This content is password protected. To view it please enter your password below: Password: The post Protected: Digital TV: A Boon for Pharma Marketers appeared first on Pharma Marketing Network.
pharmaphorum
APRIL 9, 2021
UK artificial intelligence specialist Healx has begun a partnership with two medical charities that aims to uncover new therapies for the neurodegenerative disease Friedreich’s ataxia (FA). . Healx has joined forces with Ataxia UK and the US-based Friedreich’s Ataxia Research Alliance (FARA) on the project, and will use its AI-powered drug discovery platform Healnet to try to find already used drugs that could be repurposed as treatments for FA.
Pharma Times
APRIL 8, 2021
The risk of rare blood clots is currently calculated at four people in a million who receive the vaccine
Pharma Mirror
APRIL 9, 2021
Isolation gowns are essential equipment for infection-control strategies. They are the second most used PPE items after gloves. They were originally designed for health workers but can also be worn by random people to protect them from infections when they come in contact with infected people or substances. The different types of isolation gowns There are two major types of isolation gowns made for healthcare purposes: Surgical gowns: A surgical gown is a personal protective garment that is used
Drug Channels
APRIL 9, 2021
Today’s guest post comes from William Dupere, Practice Lead and Vice President of Market Access at TrialCard. Bill discusses specific barriers to access, affordability, and adherence in the specialty pharmacy patient journey. To learn more about TrialCard’s patient access solutions, please visit their Resources page. You can also contact them at sales@trialcard.com.
Expert insights. Personalized for you.
131 
Let's personalize your content